EC Healthcare (HK:2138) has released an update.
EC Healthcare has issued a profit warning for investors, indicating an expected decrease in EBITDA by not more than 10% and a significant drop in net profit to no more than HK$25 million for the year ended 31 March 2024, in comparison to the previous year. Reasons for the decline include increased interest expenses, lower operation leverage at new service points, inflation-related operating costs, and reduced government subsidies. The company’s final financial results are still pending, and investors are urged to exercise caution when dealing in the company’s shares.
For further insights into HK:2138 stock, check out TipRanks’ Stock Analysis page.
